Knight Therapeutics's total assets for Q2 2025 were C$1.04B, an increase of 3.48% from the previous quarter. KHTRF total liabilities were C$274.89M for the fiscal quarter, a 32.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.